AAAAAA

   
Results: 1-8 |
Results: 8
Determination of sodium cromoglycate in human plasma by liquid chromatography-mass spectrometry in the turbo ion spray mode
Authors: Ozoux, ML Girault, J Malgouyat, JM Pasquier, O
Citation: Ml. Ozoux et al., Determination of sodium cromoglycate in human plasma by liquid chromatography-mass spectrometry in the turbo ion spray mode, J CHROMAT B, 765(2), 2001, pp. 179-185
Cerebrospinal fluid concentrations of quinupristin-dalfopristin in a patient with vancomycin-resistant Enterococcus faecalis ventriculitis (vol 21, pg 748, 2001)
Authors: Garey, KW Tesoro, E Muggia, V Pasquier, O Rodvold, KA
Citation: Kw. Garey et al., Cerebrospinal fluid concentrations of quinupristin-dalfopristin in a patient with vancomycin-resistant Enterococcus faecalis ventriculitis (vol 21, pg 748, 2001), PHARMACOTHE, 21(8), 2001, pp. P8-P8
Cerebrospinal fluid concentrations of quinupristin-dalfopristin in a patient with vancomycin-resistant Enterococcus faecalis ventriculitis
Authors: Garey, KW Tesoro, E Muggia, V Pasquier, O Rodvold, KA
Citation: Kw. Garey et al., Cerebrospinal fluid concentrations of quinupristin-dalfopristin in a patient with vancomycin-resistant Enterococcus faecalis ventriculitis, PHARMACOTHE, 21(6), 2001, pp. 748-750
Multiple-dose pharmacokinetics and safety of two regimens of quinupristin/dalfopristin (Synercid (R)) in healthy volunteers
Authors: Chevalier, P Rey, J Pasquier, O Rouzier-Panis, R Harding, N Montay, G
Citation: P. Chevalier et al., Multiple-dose pharmacokinetics and safety of two regimens of quinupristin/dalfopristin (Synercid (R)) in healthy volunteers, J CLIN PHAR, 41(4), 2001, pp. 404-414
The MCSE approach for system-level design
Authors: Pasquier, O Muller, F Calvez, JP Heller, D Chenard, D
Citation: O. Pasquier et al., The MCSE approach for system-level design, ELECTRONIC CHIPS & SYSTEMS DESIGN LANGUAGES, 2001, pp. 213-224
Pharmacokinetics of quinupristin/dalfopristin in patients with severe chronic renal insufficiency
Authors: Chevalier, P Rey, J Pasquier, O Leclerc, V Baguet, JC Meyrier, A Harding, N Montay, G
Citation: P. Chevalier et al., Pharmacokinetics of quinupristin/dalfopristin in patients with severe chronic renal insufficiency, CLIN PHARMA, 39(1), 2000, pp. 77-84
The Ets2 transcription factor inhibits apoptosis induced by colony-stimulating factor 1 deprivation of macrophages through a Bcl-x(L)-dependent mechanism
Authors: Sevilla, L Aperlo, C Dulic, V Chambard, JC Boutonnet, C Pasquier, O Pognonec, P Boulukos, KE
Citation: L. Sevilla et al., The Ets2 transcription factor inhibits apoptosis induced by colony-stimulating factor 1 deprivation of macrophages through a Bcl-x(L)-dependent mechanism, MOL CELL B, 19(4), 1999, pp. 2624-2634
Pharmacokinetics of quinupristin-dalfopristin in continuous ambulatory peritoneal dialysis patients
Authors: Johnson, CA Taylor, CA Zimmerman, SW Bridson, WE Chevalier, P Pasquier, O Baybutt, RI
Citation: Ca. Johnson et al., Pharmacokinetics of quinupristin-dalfopristin in continuous ambulatory peritoneal dialysis patients, ANTIM AG CH, 43(1), 1999, pp. 152-156
Risultati: 1-8 |